Quest Diagnostics (DGX) 10-K2010 Q4 Annual report

Filed: 16 Feb 11, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigious
Readability	H.S. freshman Avg

New words: AccuType, AccuTypeTMCP, AccuTypeTMMetformin, acute, adapt, additon, aimed, aircraft, ALK, allele, ambulatory, AmeriPathTM, Argentina, ASR, basket, billable, biology, Blot, Brazil, Carey, category, charity, chart, ColoVantageTMtest, commericialization, comparison, CPI, CPT, deepened, defective, Dermpath, detrimental, DiagnosticsTMand, Discrimination, Editorial, EFGR, Essex, EU, excise, exisiting, faith, fast, Flu, forty, Gazelle, GazelleTM, grandfathered, grown, HealthTMin, HealthVaultTM, impending, intervention, iPad, iPhone®or, IUO, KeasTM, Leumeta®family, Meaningful, mechanism, medMATCH, metformin, milestone, Mitsubishi, motion, obligor, officially, panel, persuasive, postponed, preserving, rescind, resigned, revaluation, Rockefeller, RSV, RUO, School, sexual, shape, SimplexaTM, smartphone, stemming, storm, SureSwab, SureSwabTM, survey, technique, temperature, TestMinderTM, timetable, Tokyo, transmission, University, unknown, unregistered, unspecified, update, vigorously, Wellness®directly, Wellness®program, XSense

Removed: ABN, achieving, aggregation, anemia, apply, asin, breakdown, bridge, cervical, challenging, chemotherapy, clarify, coast, consolidate, controlling, conventional, converted, convertible, curative, decade, deconsolidation, deficient, denied, deployed, dermatopathology, disclosing, entry, expensing, expressing, family, frequency, gaining, grossly, Gulf, HLA, inclusion, indemnify, Industrial, infection, informed, initially, instant, instituted, insured, irrevocable, justified, LabOne, Lenexa, Leumeta, lock, lost, medically, methodology, misinformation, modified, morbidity, moving, Multivariate, negotiation, online, optimization, owed, peer, permitted, personally, portal, presenting, produce, prospective, prospectively, realistic, recording, redefining, refinanced, regulate, rest, restrict, retained, route, scale, screen, split, statutorily, streamlined, subset, threatened, transfusion, undergoing, UNH, unqualified, unreasonable, weekly, whistle, women

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

DGX similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. § 1350,
AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Pursuant to 18 U.S.C. § 1350, the undersigned certifies that, to the best of my knowledge, the Annual Report on Form 10-K for the period ended December 31, 2010 of Quest Diagnostics Incorporated, as being filed with the Securities and Exchange Commission concurrently herewith, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. § 78m or 78o(d)) and that the information contained in the Annual Report fairly presents, in all material respects, the financial condition and results of operations of Quest Diagnostics Incorporated.


Dated:	February 16, 2011	/s/ Surya N. Mohapatra

		Surya N. Mohapatra, Ph.D.
		Chairman of the Board, President and
		Chief Executive Officer